nirogacestat
springworks therapeutics
[]
spontaneous growth arrest &amp; regression occurs in as many as 50-60% of the patients. also niro discontinuation will have to be planned. 
Chair Sarcoma Service - Department of Surgery - National Cancer Institute - Milan - Italy.